Clinical Trials Directory

Trials / Terminated

TerminatedNCT03151226

OSA Screen Negative With Spinal Duramorph

A Prospective, Observational, Double-blind (Black-Box) Study Evaluating Incidence, Severity and Predictive Factors of Respiratory Depression and Sleep Disorder Pattern During Postoperative Neuraxial Opioid Analgesia in OSA Screened Negative With BMI>=35 Kg/m2 Obstetric Patients After Cesarean Delivery Using Current Standard Intermittent Postoperative Monitoring Compared to Continuous Pulse Oximetry/Capnography

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
3 (actual)
Sponsor
Wake Forest University Health Sciences · Academic / Other
Sex
Female
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

Non emergent scheduled cesarean sections will be consented to participate in this study of patients who have screened negative for obstructive sleep apnea and who are also BMI\>/= 35 to have capnography monitoring postoperatively. The capnography and pulse oximetry will be initiated in the post anesthesia care unit and be worn for 12-24 hours after delivery. Data will be retrieved after that time period in a deidentified fashion. Medication usage will be reviewed as well as the standard of care information from the duramorph monitoring will be retrieved.

Conditions

Interventions

TypeNameDescription
DEVICECapnography monitoringcapnography and pulse oximetry will be initiated in the recovery room and worn for 12-24 hours post delivery

Timeline

Start date
2015-08-03
Primary completion
2015-10-01
Completion
2015-10-01
First posted
2017-05-12
Last updated
2018-09-07
Results posted
2018-03-08

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03151226. Inclusion in this directory is not an endorsement.

OSA Screen Negative With Spinal Duramorph (NCT03151226) · Clinical Trials Directory